Label: NALOXONE HYDROCHLORIDE spray

  • NDC Code(s): 45802-578-00, 45802-578-84
  • Packager: Padagis Israel Pharmaceuticals Ltd
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated July 25, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredient (in each spray)

    Naloxone hydrochloride 4 mg

  • Purpose

    Emergency treatment of opioid overdose

  • Uses

    • to “revive” someone during an overdose from many prescription pain medications or street drugs such as heroin

    • this medicine can save a life

  • Directions

    Step 1

    Step 1: CHECK if you suspect an overdose:

    • CHECK for a suspected overdose: the person will not wake up or is very sleepy or not breathing well

    • yell “Wake up!”

    • shake the person gently

    • if the person is not awake, go to Step 2
    Step 2

    Step 2: GIVE 1st dose in the nose

    • HOLD the nasal spray device with your thumb on the bottom of the plunger

    • INSERT the nozzle into either NOSTRIL

    • PRESS the plunger firmly to give the 1st dose

    • 1 nasal spray device contains 1 dose
    Step 3

    Step 3: CALL

    • CALL 911immediately after giving the 1st dose
    Step 4

    Step 4: WATCH & GIVE

    • WAIT2-3 minutes after the 1st dose to give the medicine time to work

    • if the person wakes up: Go to Step 5

    • if the person does not wake up:

       • CONTINUE TO GIVE doses every 2-3 minutes until the person wakes up

       • it is safe to keep giving doses
    Step 5

    Step 5: STAY

    • STAY until ambulance arrives: even if the person wakes up

    • GIVE another dose if the person becomes very sleepy again

    • You may need to give all the doses in the pack
  • Warning

    When using this product some people may experience symptoms when they wake up, such as shaking, sweating, nausea, or feeling angry. This is to be expected.

  • Other information

    • store at room temperature or refrigerated, between 2°C to 25°C (36°F to 77°F)

    • do not freeze

    • avoid excessive heat above 40°C (104°F)

    • protect from light

    • the product is packaged in individually-sealed blisters.

       Do not use if the blister is open or torn, or if the device appears damaged

  • Inactive Ingredients

    benzalkonium chloride, edetate disodium, hydrochloric acid, sodium chloride, water

  • Questions?

     
    call 1-866-634-9120 or go to www.padagis.com
  • Package/Label Principal Display Panel

    NDC 45802-578-84

    Naloxone HCl Nasal Spray 4 mg

    Emergency Treatment of Opioid Overdose

    Original Prescription Strength

    Easy to Use

    Can Save a Life

    Designed to Rapidly Reverse the Effects of a Life-Threatening Opioid Emergency

    For use in nose only

    2 Single-Dose Nasal Spray Devices

    0.003 fl oz (0.1mL) each

    carton
  • INGREDIENTS AND APPEARANCE
    NALOXONE HYDROCHLORIDE 
    naloxone hydrochloride spray
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:45802-578
    Route of AdministrationNASAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    NALOXONE HYDROCHLORIDE (UNII: F850569PQR) (NALOXONE - UNII:36B82AMQ7N) NALOXONE HYDROCHLORIDE4 mg  in 0.1 mL
    Inactive Ingredients
    Ingredient NameStrength
    BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    HYDROCHLORIC ACID (UNII: QTT17582CB)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:45802-578-842 in 1 CARTON07/30/2023
    1NDC:45802-578-000.1 mL in 1 VIAL, SINGLE-DOSE; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21195107/30/2023
    Labeler - Padagis Israel Pharmaceuticals Ltd (600093611)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!